Skip to content
Thursday, November 19, 2026
Gold Culture Site

Patients Stopping Slimming Medications Gain Back Pounds Four Times Faster Compared to Dieters

Image of medical injection and weighing machine
Weight management often requires long-term strategies.

A recent study indicates that individuals who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro may regain lost weight at a significantly accelerated pace than those who end conventional diet and exercise programs.

Findings released in a leading medical journal demonstrates that while obese people frequently drop about a fifth of their body weight while on the medication, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.

"Users buying these medications should be aware of the potential of quick rebound weight gain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.

That rate of recovery means a reversion to pre-treatment mass within about 18 months.

Comparing Approaches

The study, which reviewed dozens of studies involving over 9,000 of participants, contrasted the results of these new drugs with conventional dieting.

The team point out that individuals who lose weight through dieting usually see a more gradual creep back—perhaps 0.1 kg a month—post-intervention.

Understanding the Rapid Rebound

Nutrition scientists propose the way of the drugs is key to understanding the amplified rebound.

GLP-1 drugs imitate a natural hormone called GLP-1, which helps regulate appetite.

"Long-term administration of GLP-1 levels several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Stopping of this medication leads to hunger is unsuppressed, making overeating much more probable."

A Chronic Issue?

Medical guidelines advise the injections for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.

Professionals say that, given the high risk of weight regain, the therapy is often life-long.

This opinion is echoed by drug manufacturers, who state that the results "underscore the chronic nature of excess weight," similar to managing diseases like high blood pressure.

Patient Accounts

Individuals who have discontinued the medication report a powerful return of cravings.

"It was like a trigger flipping and you're instantly starving," recalled one woman.

This challenge is exacerbated if patients have not adopted lasting lifestyle or habit changes during therapy.

Significant Adoption

Recent estimates suggest that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.

  • Use is higher among women compared to men.
  • The 40s and 50s age group shows the highest usage rates.
  • Many access the medications through private prescriptions rather than public health services.

In conclusion, researchers caution that while these medications are effective agents for shedding pounds, they are not a magic solution and long-term success likely depends on combined lifestyle support.

About the author

Taylor Peterson

A UK-based jewelry historian with over 15 years of expertise in luxury metals and cultural trends.

Gold Culture Site

Type to search articles.